Graves Disease
121
36
39
57
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Research Maturity
57 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.5%
3 terminated out of 121 trials
95.0%
+8.5% vs benchmark
15%
18 trials in Phase 3/4
14%
8 of 57 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 57 completed trials
Clinical Trials (121)
Study of BHV-1300 in Graves' Disease
Telehealth Music Therapy for Adults With Endocrine Disorder and Depression
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid Eye Disease: The TED SCOPE National Multicenter Registry Study
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
Natural History of Thyroid Function Disorders
Evaluating an AI Tool for Detecting Thyrotoxic States
BASE-DIET: a Study on Nutritional Intervention in Patients With Graves' Disease
In Vivo CAR-T for Refractory Graves' Disease
Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease
A Study of GensSci098 in Subjects With Graves' Disease
Impact of Thyroid Hormones on Human Glucose and Energy Metabolism